Stem cell factor and granulocyte colony-stimulating factor promote brain repair and improve cognitive function through VEGF-A in a mouse model of CADASIL

被引:21
|
作者
Ping, Suning [1 ]
Qiu, Xuecheng [1 ]
Kyle, Michele [1 ]
Hughes, Karen [1 ]
Longo, John [1 ]
Zhao, Li-Ru [1 ]
机构
[1] SUNY Upstate Med Univ, Dept Neurosurg, 750 E Adams St, Syracuse, NY 13210 USA
关键词
CADASIL; SCF; G-CSF; VEGF; VEGF-A; AUTOSOMAL-DOMINANT ARTERIOPATHY; ENDOTHELIAL GROWTH-FACTOR; NF-KAPPA-B; POSITRON-EMISSION-TOMOGRAPHY; CEREBRAL-BLOOD-FLOW; SUBCORTICAL INFARCTS; ALZHEIMERS-DISEASE; NOTCH3; MUTATIONS; PATHOLOGICAL PROCESSES; ADULT NEUROGENESIS;
D O I
10.1016/j.nbd.2019.104561
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cerebral autosomal dominant arteriopathy with subcortical infarct and leukoencephalopathy (CADASIL) is a cerebral small vascular disease caused by NOTCH3 gene mutation in vascular smooth muscle cells (VSMCs), leading to ischemic stroke and vascular dementia. To date, the pathogenesis of CADASIL remains poorly understood, and there is no treatment that can slow the progression of CADASIL. Using a transgenic mouse model of CADASIL (TgNotch3R90C), this study reveals novel findings for understanding CADASIL pathogenesis that decreased cerebral vascular endothelial growth factor (VEGF/VEGF-A) is linked to reduced cerebral blood vessel density. Reduced endothelial cell (EC) proliferation and angiogenesis are seen in TgNotch3R90C mouse brain-isolated ECs. Decreased dendrites, axons, and synapses in the somatosensory and motor cortex layer 2/3 and in the hippocampal CA1, and reduced neurogenesis in both the subventricular zone and subgranular zone occur in 15-month-old TgNotch3R90C mice. These reductions in neuron structures, synapses, and neurogenesis are significantly correlated to decreased cerebral vasculature in the corresponding areas. Impaired spatial learning and memory in TgNotch3R90C mice are significantly correlated with the reduced cerebral vasculature, neuron structures, and synapses. Repeated treatment of stem cell factor and granulocyte colony-stimulating factor (SCF+G-CSF) at 9 and 10 months of age improves cognitive function, increases cerebral VEGF/VEGF-A, restores cerebral vasculature, and enhances regeneration of neuronal structures, synaptogenesis and neurogenesis in TgNotch3R90C mice. Pretreatment with Avastin, an angiogenesis inhibitor by neutralizing VEGF-A, completely eliminates the SCF+G-CSF-enhanced cognitive function, vascular and neuronal structure regeneration, synaptogenesis and neurogenesis in TgNotch3R90C mice. SCF+G-CSF-enhanced EC proliferation and angiogenesis in TgNotch3R90C mouse brain-isolated ECs are also blocked by Avastin pretreatment. These data suggest that SCF+G-CSF treatment may repair Notch3R90C mutation-damaged brain through the VEGF-A-mediated angiogenesis. This study provides novel insight into the involvement of VEGF/VEGF-A in the pathogenesis of CADASIL and sheds light on the mechanism underlying the SCF+G-CSF-enhanced brain repair in CADASIL.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Mechanism of mobilization of mesenchymal stem cell under the effect of granulocyte colony-stimulating factor
    Zhdanov, V. V.
    Stavrova, L. A.
    Dygai, A. M.
    Goldberg, E. D.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2007, 144 (01) : 151 - 153
  • [32] Concurrent administration of granulocyte colony-stimulating factor or granulocyte-monocyte colony-stimulating factor enhances the biological activity of rituximab in a severe combined immunodeficiency mouse lymphoma model
    Hernandez-Ilizaliturri, FJ
    Jupudy, V
    Reising, S
    Repasky, EA
    Czuczman, MS
    LEUKEMIA & LYMPHOMA, 2005, 46 (12) : 1775 - 1784
  • [33] Mechanism of mobilization of mesenchymal stem cell under the effect of granulocyte colony-stimulating factor
    V. V. Zhdanov
    L. A. Stavrova
    A. M. Dygai
    E. D. Goldberg
    Bulletin of Experimental Biology and Medicine, 2007, 144 : 151 - 153
  • [34] The clinical applications of granulocyte colony-stimulating factor in hematopoietic stem cell transplantation: A review
    Tabbara, IA
    Ghazal, CD
    Ghazal, HH
    ANTICANCER RESEARCH, 1996, 16 (6B) : 3901 - 3905
  • [35] Granulocyte colony-stimulating factor and stem cell factor improve contractile reserve of the infarcted left ventricle independent of restoring muscle mass
    Sesti, C
    Hale, SL
    Lutzko, C
    Kloner, RA
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (09) : 1662 - 1669
  • [36] NF-κB is involved in brain repair by stem cell factor and granulocyte-colony stimulating factor in chronic stroke
    Cui, Lili
    Duchamp, Nicolas S.
    Boston, Dakota J.
    Ren, Xuefang
    Zhang, Xiangjian
    Hu, Heng
    Zhao, Li-Ru
    EXPERIMENTAL NEUROLOGY, 2015, 263 : 17 - 27
  • [37] Synergism between stem cell factor and granulocyte-macrophage colony-stimulating factor on cell proliferation by induction of cyclins
    Kamijo, T
    Koike, K
    Nakazawa, Y
    Takeuchi, K
    Ishii, E
    Komiyama, A
    CYTOKINE, 2002, 19 (06) : 267 - 275
  • [38] Mobilization efficiency of granulocyte colony-stimulating factor and stem cell factor to bone marrow mononuclear cells and mechanisms
    Deyu Duan
    Baojun Xiao
    Shuhua Yang
    Zengwu Shao
    Hong Wang
    Xiaodong Guo
    Yong Liu
    Zhewei Ye
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2010, 30 : 477 - 481
  • [39] Mobilization efficiency of granulocyte colony-stimulating factor and stem cell factor to bone marrow mononuclear cells and mechanisms
    Duan, Deyu
    Xiao, Baojun
    Yang, Shuhua
    Shao, Zengwu
    Wang, Hong
    Guo, Xiaodong
    Liu, Yong
    Ye, Zhewei
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2010, 30 (04) : 477 - 481
  • [40] Meta-analysis of randomized controlled trials of prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor after autologous and allogeneic stem cell transplantation
    Dekker, Allison
    Bulley, Sean
    Beyene, Joseph
    Dupuis, L. Lee
    Doyle, John J.
    Sung, Lillian
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (33) : 5207 - 5215